The first imported generic drug approved under China QCE system
On May 6th, the generic pharmaceuticals company Sandoz announced that it has received regulatory approval from China’s National Medical Products Administration (NMPA) for its generic Rosuvastatin (a cardiovascular drug belongs to statin medicine group), under the NMPA’s Quality Consistency Evaluation (QCE) system. As the first approved generic drug under the QCE system in China applied…
